Skip to main content
Top
Published in: BMC Infectious Diseases 1/2009

Open Access 01-12-2009 | Research article

The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients

Authors: Pasqual Barretti, Augusto C Montelli, Jackson EN Batalha, Jacqueline CT Caramori, Maria de Lourdes RS Cunha

Published in: BMC Infectious Diseases | Issue 1/2009

Login to get access

Abstract

Background

Peritonitis continues to be the most frequent cause of peritoneal dialysis (PD) failure, with an important impact on patient mortality. Gram-positive cocci such as Staphylococcus epidermidis, other coagulase-negative staphylococci (CoNS), and Staphylococcus aureus are the most frequent etiological agents of PD-associated peritonitis worldwide. The objective of the present study was to compare peritonitis caused by S. aureus and CoNS and to evaluate the factors influencing outcome.

Methods

Records of 86 new episodes of staphylococcal peritonitis that occurred between 1996 and 2000 in the Dialysis unit of a single university hospital were studied (35 due to S. aureus, 24 to S. epidermidis and 27 to other CoNS). The production of slime, lipase, lecithinase, nuclease (DNAse), thermonuclease (TNAse), α- and β-hemolysin, enterotoxins (SEA, SEB, SEC, SED) and toxic shock syndrome toxin-1 (TSST-1) was studied in S. aureus and CoNS. Antimicrobial susceptibility was evaluated based on the minimal inhibitory concentration determined by the E-test. Outcome predictors were evaluated by two logistic regression models.

Results

The oxacillin susceptibility rate was 85.7% for S. aureus, 41.6% for S. epidermidis, and 51.8% for other CoNS (p = 0.001). Production of toxins and enzymes, except for enterotoxin A and α-hemolysin, was associated with S. aureus episodes (p < 0.001), whereas slime production was positive in 23.5% of CoNS and 8.6% of S. aureus strains (p = 0.0047). The first model did not include enzymes and toxins due to their association with S. aureus. The odds of resolution were 9.5 times higher for S. epidermidis than for S. aureus (p = 0.02) episodes, and were similar for S. epidermidis and other CoNS (p = 0.8). The resolution odds were 68 times higher for non-slime producers (p = 0.001) and were not influenced by oxacillin resistance among vancomycin-treated cases (p = 0.89). In the second model, the resolution rate was similar for S. aureus and S. epidermidis (p = 0.70), and slime (p = 0.001) and α-hemolysin (p = 0.04) production were independent predictors of non-resolution.

Conclusion

Bacterial species and virulence factors rather than antibiotic resistance influence the outcome of staphylococcal peritonitis.
Literature
1.
go back to reference Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: The London, UK, Peritonitis Audit 2002-2003. Perit Dial Int. 2009, 29: 297-302.PubMed Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: The London, UK, Peritonitis Audit 2002-2003. Perit Dial Int. 2009, 29: 297-302.PubMed
2.
go back to reference Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F: Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005, 25: 274-84.PubMed Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F: Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005, 25: 274-84.PubMed
3.
4.
go back to reference Troidle L, Gorban-Brennan N, Kliger A, Finkeltein F: Differing outcomes of gram-positive and gram-negative. Am J Kidney Dis. 1998, 32: 623-628. 10.1016/S0272-6386(98)70026-5.CrossRefPubMed Troidle L, Gorban-Brennan N, Kliger A, Finkeltein F: Differing outcomes of gram-positive and gram-negative. Am J Kidney Dis. 1998, 32: 623-628. 10.1016/S0272-6386(98)70026-5.CrossRefPubMed
5.
go back to reference Bunke CM, Brier ME, Golper TA: Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int. 1997, 52: 524-529. 10.1038/ki.1997.363.CrossRefPubMed Bunke CM, Brier ME, Golper TA: Outcomes of single organism peritonitis in peritoneal dialysis: gram negatives versus gram positives in the Network 9 Peritonitis Study. Kidney Int. 1997, 52: 524-529. 10.1038/ki.1997.363.CrossRefPubMed
6.
go back to reference Peacock SJ, Howe PA, Day NP, Crook DW, Winearls CG, Berendt AR: Outcome following staphylococcal peritonitis. Perit Dial Int. 2000, 20: 215-219.PubMed Peacock SJ, Howe PA, Day NP, Crook DW, Winearls CG, Berendt AR: Outcome following staphylococcal peritonitis. Perit Dial Int. 2000, 20: 215-219.PubMed
7.
go back to reference Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, Vas SI, Oreopoulos DG: Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002, 22: 573-581.PubMed Krishnan M, Thodis E, Ikonomopoulos D, Vidgen E, Chu M, Bargman JM, Vas SI, Oreopoulos DG: Predictors of outcome following bacterial peritonitis in peritoneal dialysis. Perit Dial Int. 2002, 22: 573-581.PubMed
8.
go back to reference de Lourdes Ribeiro de Souza da Cunha M, Montelli AC, Fioravante AM, Neves Batalha JE, Texeira Caramori JC, Barretti P: Predictive factors of outcome following staphylococcal peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol. 2005, 64: 378-382.CrossRefPubMed de Lourdes Ribeiro de Souza da Cunha M, Montelli AC, Fioravante AM, Neves Batalha JE, Texeira Caramori JC, Barretti P: Predictive factors of outcome following staphylococcal peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol. 2005, 64: 378-382.CrossRefPubMed
9.
go back to reference Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, Lee HY, Han DS, Kang SW: Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int. 2004, 24: 424-432.PubMed Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, Lee HY, Han DS, Kang SW: Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int. 2004, 24: 424-432.PubMed
10.
go back to reference Holley JL, Bernadini J, Johnston JR, Piraino B: Methicillin-resistant staphylococcal Infections in an outpatient peritoneal dialysis program. Am J Kidney Dis. 1990, 16: 142-146.CrossRefPubMed Holley JL, Bernadini J, Johnston JR, Piraino B: Methicillin-resistant staphylococcal Infections in an outpatient peritoneal dialysis program. Am J Kidney Dis. 1990, 16: 142-146.CrossRefPubMed
11.
go back to reference Kristinsson KG, Spencer RC, Hastings JGM, Brown CB: Slime production by coagulase negative Staphylococci - a major virulence factor?. Contr Nephrol. 1987, 57: 79-84.CrossRef Kristinsson KG, Spencer RC, Hastings JGM, Brown CB: Slime production by coagulase negative Staphylococci - a major virulence factor?. Contr Nephrol. 1987, 57: 79-84.CrossRef
12.
go back to reference Vogel L, Sloos JH, Spaargaren J, Suiker I, Dijkshoorn L: Biofilm production by Staphylococcus epidermidis isolates associated with catheter related bacteremia. Diagn Microbiol Infect Dis. 2000, 36: 139-41. 10.1016/S0732-8893(99)00124-8.CrossRefPubMed Vogel L, Sloos JH, Spaargaren J, Suiker I, Dijkshoorn L: Biofilm production by Staphylococcus epidermidis isolates associated with catheter related bacteremia. Diagn Microbiol Infect Dis. 2000, 36: 139-41. 10.1016/S0732-8893(99)00124-8.CrossRefPubMed
13.
go back to reference Kristinsson KG, Spencer RC, Brown CB: Clinical importance of production of slime by coagulase negative staphylococci in chronic ambulatory peritoneal dialysis. J Clin Pathol. 1986, 39: 117-118. 10.1136/jcp.39.1.117.CrossRefPubMedPubMedCentral Kristinsson KG, Spencer RC, Brown CB: Clinical importance of production of slime by coagulase negative staphylococci in chronic ambulatory peritoneal dialysis. J Clin Pathol. 1986, 39: 117-118. 10.1136/jcp.39.1.117.CrossRefPubMedPubMedCentral
14.
go back to reference Alexander W, Rimland D: Lack of correlation of slime production with pathogenicity in continuous ambulatory peritoneal dialysis peritonitis caused by coagulase negative staphylococci. Diagn Microbiol Infect Dis. 1987, 8: 215-220. 10.1016/0732-8893(87)90052-6.CrossRefPubMed Alexander W, Rimland D: Lack of correlation of slime production with pathogenicity in continuous ambulatory peritoneal dialysis peritonitis caused by coagulase negative staphylococci. Diagn Microbiol Infect Dis. 1987, 8: 215-220. 10.1016/0732-8893(87)90052-6.CrossRefPubMed
15.
go back to reference de Lourdes Ribeiro de Souza da Cunha M, Caramori JC, Fioravante AM, Batalha JE, Montelli AC, Barretti P: Significance of slime as virulence factor in coagulase-negative staphylococcus peritonitis in CAPD. Perit Dial Int. 2004, 24: 191-193. de Lourdes Ribeiro de Souza da Cunha M, Caramori JC, Fioravante AM, Batalha JE, Montelli AC, Barretti P: Significance of slime as virulence factor in coagulase-negative staphylococcus peritonitis in CAPD. Perit Dial Int. 2004, 24: 191-193.
16.
go back to reference Dingues MM, Orwin PM, Schlievert M: Exotoxins of Staphylococcus aureus. Clin Microb Reviews. 2000, 13: 16-34. 10.1128/CMR.13.1.16-34.2000.CrossRef Dingues MM, Orwin PM, Schlievert M: Exotoxins of Staphylococcus aureus. Clin Microb Reviews. 2000, 13: 16-34. 10.1128/CMR.13.1.16-34.2000.CrossRef
17.
go back to reference Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Huang CC, Kawaguchi Y, Piraino B, Riella M, Schaefer F, Vas S: Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int. 1996, 16: 557-573.PubMed Keane WF, Alexander SR, Bailie GR, Boeschoten E, Gokal R, Golper TA, Holmes CJ, Huang CC, Kawaguchi Y, Piraino B, Riella M, Schaefer F, Vas S: Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update. Perit Dial Int. 1996, 16: 557-573.PubMed
18.
go back to reference Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Clifford JH, Kawaguchi Y, Piraino B, Riella M, Vas S: Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000, 20: 396-411.PubMed Keane WF, Bailie GR, Boeschoten E, Gokal R, Golper TA, Clifford JH, Kawaguchi Y, Piraino B, Riella M, Vas S: Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int. 2000, 20: 396-411.PubMed
19.
go back to reference Kloos WE, Schleifer KH: Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol. 1975, 1: 82-88.PubMedPubMedCentral Kloos WE, Schleifer KH: Simplified scheme for routine identification of human Staphylococcus species. J Clin Microbiol. 1975, 1: 82-88.PubMedPubMedCentral
20.
go back to reference Kloos WE, Bannerman TL: Staphylococcus and Micrococcus. Manual of Clinical Microbiology. Edited by: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. 1995, Washington, American Society Microbiology, 282-298. Kloos WE, Bannerman TL: Staphylococcus and Micrococcus. Manual of Clinical Microbiology. Edited by: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH. 1995, Washington, American Society Microbiology, 282-298.
21.
go back to reference Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: CLSI approved standard M100-S15. Wayne PA USA. 2005 Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing: CLSI approved standard M100-S15. Wayne PA USA. 2005
22.
go back to reference Christensen GD: Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982, 37: 318-326.PubMedPubMedCentral Christensen GD: Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982, 37: 318-326.PubMedPubMedCentral
23.
go back to reference Jessen O, Faber V, Rosendal K, Eriksen KR: Some properties of Staphylococcus aureus, possibly related to pathogenicity. Part 1. A study of 446 strains from different types of human infection. Acta Pathol Microbiol Scand. 1959, 47: 316-326.CrossRefPubMed Jessen O, Faber V, Rosendal K, Eriksen KR: Some properties of Staphylococcus aureus, possibly related to pathogenicity. Part 1. A study of 446 strains from different types of human infection. Acta Pathol Microbiol Scand. 1959, 47: 316-326.CrossRefPubMed
24.
go back to reference Matos JE, Harmon RJ, Langlois BE: Lecithinase reaction of Staphylococcus aureus strains of different origin on Baird-Parker medium. Lett Appl Microbiol. 1995, 21: 334-335. 10.1111/j.1472-765X.1995.tb01073.x.CrossRefPubMed Matos JE, Harmon RJ, Langlois BE: Lecithinase reaction of Staphylococcus aureus strains of different origin on Baird-Parker medium. Lett Appl Microbiol. 1995, 21: 334-335. 10.1111/j.1472-765X.1995.tb01073.x.CrossRefPubMed
25.
go back to reference Lachica RUF, Genigeorgis C, Hoeprich PD: Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol. 1971, 21: 585-587.PubMedPubMedCentral Lachica RUF, Genigeorgis C, Hoeprich PD: Metachromatic agar-diffusion methods for detecting staphylococcal nuclease activity. Appl Microbiol. 1971, 21: 585-587.PubMedPubMedCentral
26.
go back to reference Donnelly CB: Serological identification of enterotoxigenic staphylococci from cheese. Appl Microbiol. 1967, 15: 1382-1387.PubMedPubMedCentral Donnelly CB: Serological identification of enterotoxigenic staphylococci from cheese. Appl Microbiol. 1967, 15: 1382-1387.PubMedPubMedCentral
27.
go back to reference Shingaki MH, Igarashi H, Fujikawa H, Ushioda H, Terayama T, Sakai S: Study on reversed passive latex agglutination for the detection of staphylococcal enterotoxins A-C. Annu Rep Tokyo Metr Res Lab Publ Hlth. 1981, 32: 128-131. Shingaki MH, Igarashi H, Fujikawa H, Ushioda H, Terayama T, Sakai S: Study on reversed passive latex agglutination for the detection of staphylococcal enterotoxins A-C. Annu Rep Tokyo Metr Res Lab Publ Hlth. 1981, 32: 128-131.
28.
go back to reference Gruer LD, Bartlett R, Ayliffe GA: Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis. J Antimicrob Chemother. 1984, 13: 577-583. 10.1093/jac/13.6.577.CrossRefPubMed Gruer LD, Bartlett R, Ayliffe GA: Species identification and antibiotic sensitivity of coagulase-negative staphylococci from CAPD peritonitis. J Antimicrob Chemother. 1984, 13: 577-583. 10.1093/jac/13.6.577.CrossRefPubMed
29.
go back to reference Golper T: Intermittent versus continuous antibiotics for PD-related peritonitis. Perit Dial Int. 1997, 17: 11-12.PubMed Golper T: Intermittent versus continuous antibiotics for PD-related peritonitis. Perit Dial Int. 1997, 17: 11-12.PubMed
30.
go back to reference Haslinger-Loffler B, Wagner B, Bruck M, Strangfeld K, Grundmeier M, Fischer U, Volker W, Peters G, Schulze-Osthoff K, Sinha B: Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells. Kidney Int. 2006, 70: 1089-1098. 10.1038/sj.ki.5001710.CrossRefPubMed Haslinger-Loffler B, Wagner B, Bruck M, Strangfeld K, Grundmeier M, Fischer U, Volker W, Peters G, Schulze-Osthoff K, Sinha B: Staphylococcus aureus induces caspase-independent cell death in human peritoneal mesothelial cells. Kidney Int. 2006, 70: 1089-1098. 10.1038/sj.ki.5001710.CrossRefPubMed
31.
go back to reference Glik A, Douvdevani A: Tlymphocytes: the "cellular" arm of acquired immunity in the peritoneum. Perit Dial Int. 2006, 26: 438-448.PubMed Glik A, Douvdevani A: Tlymphocytes: the "cellular" arm of acquired immunity in the peritoneum. Perit Dial Int. 2006, 26: 438-448.PubMed
Metadata
Title
The role of virulence factors in the outcome of staphylococcal peritonitis in CAPD patients
Authors
Pasqual Barretti
Augusto C Montelli
Jackson EN Batalha
Jacqueline CT Caramori
Maria de Lourdes RS Cunha
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2009
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-9-212

Other articles of this Issue 1/2009

BMC Infectious Diseases 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.